{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:35:06Z","timestamp":1791398106740,"version":"4.3.3"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund FWF","doi-asserted-by":"publisher","award":["P22521-B18"],"award-info":[{"award-number":["P22521-B18"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Austrian National Bank","doi-asserted-by":"crossref","award":["14263"],"award-info":[{"award-number":["14263"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PhD Program DK-MOLIN","award":["FWF-W1241"],"award-info":[{"award-number":["FWF-W1241"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.prostaglandins.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T19:16:07Z","timestamp":1502738167000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["The therapeutic potential of CRTH2\/DP2 beyond allergy and asthma"],"prefix":"10.1016","volume":"133","author":[{"given":"Katharina","family":"Jandl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akos","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0005-2760(73)90145-8","article-title":"Isolation and properties of intermediates in prostaglandin biosynthesis","volume":"326","author":"Nugteren","year":"1973","journal-title":"Biochim. Biophys. Acta."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0049-3848(74)90168-6","article-title":"Prostaglandin D2 inhibits the aggregation of human platelets","volume":"5","author":"Smith","year":"1974","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0049-3848(74)90176-5","article-title":"Stimulation of human platelet adenylate cyclase by prostaglandin D2","volume":"5","author":"Mills","year":"1974","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0020","first-page":"110P","article-title":"Proceedings Biological activity of prostaglandin D2 on smooth muscle","volume":"52","author":"Horton","year":"1974","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1476-5381.1976.tb07446.x","article-title":"Inflammatory effects of prostaglandin D2 in rat and human skin","volume":"56","author":"Flower","year":"1976","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0090-6980(77)90007-7","article-title":"Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog","volume":"13","author":"Wasserman","year":"1977","journal-title":"Prostaglandins"},{"issue":"5612","key":"10.1016\/j.prostaglandins.2017.08.006_bib0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/267628a0","article-title":"Effects of PGD2 on canine renal function","volume":"267","author":"Bolger","year":"1977","journal-title":"Nature"},{"issue":"5\u20136","key":"10.1016\/j.prostaglandins.2017.08.006_bib0040","first-page":"773","article-title":"The effect of prostaglandin D2 on isolated perfused guinea-pig hearts","volume":"37","author":"Taube","year":"1978","journal-title":"Acta Biol. Med. Ger."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00586598","article-title":"Prostaglandin D2 (PGD2)\u2013a potent coronary vasoconstrictor agent in the guinea pig isolated heart","volume":"302","author":"Schr\u00f6r","year":"1978","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1476-5381.1989.tb11869.x","article-title":"Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors","volume":"96","author":"Coleman","year":"1989","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1476-5381.1989.tb11816.x","article-title":"The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist","volume":"96","author":"Giles","year":"1989","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00498818","article-title":"Release of 15-keto-13, 14-dihydro-thromboxane B2 and prostaglandin D2 during anaphylaxis as measured by radioimmunoassay","volume":"305","author":"Anhut","year":"1978","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0065","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.129.4.1627","article-title":"Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE","volume":"129","author":"Lewis","year":"1982","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0070","first-page":"260","article-title":"Prostaglandin D2: the prevailing prostaglandin in an acute inflammation","author":"Peskar","year":"1979","journal-title":"Agents Actions. Suppl."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0262-1746(84)90137-9","article-title":"The effect of prostaglandin D2 (PGD2) on circulating eosinophils","volume":"15","author":"Marsden","year":"1984","journal-title":"Prostaglandins Leukot. Med."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1152\/jappl.1989.67.3.959","article-title":"Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea","volume":"67","author":"Emery","year":"1989","journal-title":"J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0085","first-page":"138","article-title":"Studies on the ocular pharmacology of prostaglandin D2","volume":"31","author":"Woodward","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.08.006_bib0090","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.148.11.3536","article-title":"Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils","volume":"148","author":"Raible","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0095","first-page":"103","article-title":"The effect of prostanoids on the function of human eosinophils","volume":"31","author":"Pr","year":"1990","journal-title":"Agents Actions. Suppl."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0100","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1182\/blood.V98.6.1942","article-title":"Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor","volume":"98","author":"Monneret","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0105","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1067\/mai.2001.119919","article-title":"Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP","volume":"108","author":"Gervais","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0115","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4049\/jimmunol.162.3.1278","article-title":"Selective expression of a novel surface molecule by human Th2 cells in vivo","volume":"162","author":"Nagata","year":"1999","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.08.006_bib0120","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"Galli MIG null, Maggi RME null, Nagata K, Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.006_bib0125","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/13543784.2016.1212838","article-title":"Prostaglandin D2 receptor antagonists in early development as potential therapeutic options for asthma","volume":"25","author":"Santus","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2222.2011.03813.x","article-title":"A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma","volume":"42","author":"Barnes","year":"2012","journal-title":"Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2017.08.006_bib0135","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/all.12042","article-title":"The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial","volume":"67","author":"Horak","year":"2012","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/all.12096","article-title":"Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis","volume":"68","author":"Straumann","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0145","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2147\/DDDT.S105142","article-title":"Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma","volume":"10","author":"Kuna","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.08.006_bib0150","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/bph.12053","article-title":"Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthma","volume":"168","author":"Schmidt","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pupt.2016.06.005","article-title":"The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma","volume":"39","author":"Erpenbeck","year":"2016","journal-title":"Pulm Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.006_bib0160","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/all.12451","article-title":"Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459","volume":"69","author":"Pettipher","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaci.2013.10.013","article-title":"Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis","volume":"133","author":"Krug","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.102.046748","article-title":"An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro","volume":"305","author":"Sugimoto","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2014.08.027","article-title":"D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells","volume":"135","author":"Stinson","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1081-1206(10)60239-6","article-title":"Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa","volume":"102","author":"Shirasaki","year":"2009","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"13","key":"10.1016\/j.prostaglandins.2017.08.006_bib0185","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1073\/pnas.1218091110","article-title":"Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement","volume":"110","author":"Murata","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.006_bib0190","doi-asserted-by":"crossref","first-page":"e108595","DOI":"10.1371\/journal.pone.0108595","article-title":"Expression of DP2 (CRTh2), a prostaglandin D\u2082 receptor, in human mast cells","volume":"9","author":"Moon","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-5793(99)01251-X","article-title":"CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s)","volume":"459","author":"Nagata","year":"1999","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0200","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaci.2015.11.012","article-title":"Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung","volume":"137","author":"Jandl","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.08.006_bib0205","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.4049\/jimmunol.170.10.4943","article-title":"Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells","volume":"170","author":"Gosset","year":"2003","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.08.006_bib0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.08.006_bib0215","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.bjp.0704973","article-title":"Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2","volume":"137","author":"Sawyer","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0220","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.bbrc.2004.02.151","article-title":"Effects of prostaglandin D2 on helper T cell functions","volume":"316","author":"Tanaka","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/intimm\/dxp031","article-title":"Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2)","volume":"21","author":"Boehme","year":"2009","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0230","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.4049\/jimmunol.174.6.3703","article-title":"Activation of the prostaglandin D2 receptor DP2\/CRTH2 increases allergic inflammation in mouse","volume":"174","author":"Spik","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/jpet.108.137992","article-title":"Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2)","volume":"326","author":"Tajima","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0240","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/mi.2015.21","article-title":"The prostaglandin D\u2082 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung","volume":"8","author":"Wojno","year":"2015","journal-title":"Mucosal. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-1119(98)00599-X","article-title":"Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family","volume":"227","author":"Abe","year":"1999","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.08.006_bib0250","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/intimm\/dxh096","article-title":"CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation","volume":"16","author":"Takeshita","year":"2004","journal-title":"Int. Immunol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0255","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.23406","article-title":"T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease","volume":"58","author":"Boin","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.prostaglandins.2017.08.006_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167729","article-title":"Prostaglandin D2 attenuates bleomycin-induced lung inflammation and pulmonary fibrosis","volume":"11","author":"Kida","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0265","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1124\/jpet.110.169250","article-title":"D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice","volume":"335","author":"van den Brule","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0270","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1254\/jphs.12275FP","article-title":"Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor","volume":"121","author":"Ayabe","year":"2013","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0275","first-page":"117","article-title":"Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin","volume":"95","author":"Thrall","year":"1979","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0280","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01606525","article-title":"Prevention of bleomycin-induced fibrosing alveolitis with indomethacin: stereological studies on rat lungs","volume":"419","author":"Mall","year":"1991","journal-title":"Virchows Arch. A: Pathol. Anat. Histopathol."},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0285","series-title":"D14 Insights into Pathogenesis of Lung Fibrosis and Granulomas [Internet]","article-title":"Prostaglandin D2 receptor, CRTH2, is critical for gamma-Delta t cell-Mediated suppression of pulmonary Inflammation\/Fibrosis induced by bleomycin","author":"Asano","year":"2011"},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0290","series-title":"D30 The Role of Inflammation in Chronic Interstitial Lung Disease [Internet]","article-title":"A role of ProstagrandinD2 and its receptor CRTH2, in bleomycin-Induced lung fibrosis model","author":"Ueda","year":"2009"},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0295","article-title":"Macrophages programmed by apoptotic cells inhibit epithelial-mesenchymal transition in lung alveolar epithelial cells via PGE2, PGD2, and HGF","volume":"6","author":"Yoon","year":"2016","journal-title":"Sci Rep [Internet]"},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.08.006_bib0300","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1172\/JCI79792","article-title":"Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease","volume":"125","author":"Zhou","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0305","series-title":"The Effect of a Selective CRTh2 Antagonist on Tobacco Smoke (TS) Induced Airway Inflammation and Remodelling in the Mouse","author":"Sargent","year":"2009"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0310","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.109.161919","article-title":"Pharmacological blockade of the DP2 receptor inhibits cigarette smoke-induced inflammation, mucus cell metaplasia, and epithelial hyperplasia in the mouse lung","volume":"332","author":"Stebbins","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.08.006_bib0315","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.rmed.2013.06.006","article-title":"Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD","volume":"107","author":"Snell","year":"2013","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0320","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000045937","article-title":"Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus","volume":"87","author":"Hirawa","year":"2001","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0325","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000076407","article-title":"Lipocalin-type prostaglandin D synthase in urine in adriamycin-induced nephropathy of mice","volume":"96","author":"Tsuchida","year":"2004","journal-title":"Nephron Physiol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.08.006_bib0330","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1681\/ASN.2012020126","article-title":"PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis","volume":"23","author":"Ito","year":"2012","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.006_bib0335","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ecco-jcc\/jjw061","article-title":"Eosinophils contribute to intestinal inflammation via chemoattractant receptor-homologous molecule expressed on Th2Cells, CRTH2, in experimental crohn\u2019s disease","volume":"10","author":"Radnai","year":"2016","journal-title":"J. Crohns. Colitis."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0340","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.1303484","article-title":"Opposing roles of Prostaglandin D2 receptors in ulcerative colitis","volume":"193","author":"Sturm","year":"2014","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.006_bib0345","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1440-1746.2003.03088.x","article-title":"Differential expression of CCR5 and CRTH2 on infiltrated cells in colonic mucosa of patients with ulcerative colitis","volume":"18","author":"Matsuzaki","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0350","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1159\/000331326","article-title":"Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy","volume":"3","author":"Johnsson","year":"2011","journal-title":"J. Innate. Immun."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.08.006_bib0355","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/all.13140","article-title":"Differences in eosinophil molecular profiles between children and adults with eosinophilic esophagitis","volume":"72","author":"Lingblom","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0360","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0090-6980(91)90001-V","article-title":"Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification","volume":"41","author":"Tasaki","year":"1991","journal-title":"Prostaglandins"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0365","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1054\/plef.1999.0089","article-title":"Prostaglandin D2 induces interleukin-6 synthesis via Ca2+ mobilization in osteoblasts: regulation by protein kinase C","volume":"61","author":"Tokuda","year":"1999","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0370","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1359\/JBMR.041211","article-title":"Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors","volume":"20","author":"Gallant","year":"2005","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.08.006_bib0375","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1359\/jbmr.080228","article-title":"Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts","volume":"23","author":"Durand","year":"2008","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0380","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bone.2012.06.003","article-title":"Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway","volume":"3","author":"Yue","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.prostaglandins.2017.08.006_bib0385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bone.2013.12.011","article-title":"Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1\/2 and Akt signaling pathways","volume":"60","author":"Yue","year":"2014","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.prostaglandins.2017.08.006_bib0390","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.4049\/jimmunol.1303478","article-title":"A deficiency in the prostaglandin D2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation","volume":"193","author":"Tsubosaka","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0395","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.30656","article-title":"Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis","volume":"64","author":"Maicas","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.08.006_bib0400","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.febslet.2008.01.050","article-title":"Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice","volume":"582","author":"Ohinata","year":"2008","journal-title":"FEBS Lett."},{"issue":"20","key":"10.1016\/j.prostaglandins.2017.08.006_bib0405","doi-asserted-by":"crossref","first-page":"11674","DOI":"10.1073\/pnas.201398898","article-title":"Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep","volume":"98","author":"Mizoguchi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"47","key":"10.1016\/j.prostaglandins.2017.08.006_bib0410","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1073\/pnas.0608581103","article-title":"Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep","volume":"103","author":"Qu","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0415","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/bbrc.1999.0587","article-title":"Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells","volume":"258","author":"Satoh","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0420","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1124\/mol.63.3.607","article-title":"Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2","volume":"63","author":"Jung","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0425","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1254\/jphs.10001SC","article-title":"15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells","volume":"113","author":"Hatanaka","year":"2010","journal-title":"J. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0430","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.stem.2008.09.017","article-title":"Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation","volume":"3","author":"Di Giorgio","year":"2008","journal-title":"Cell Stem Cell."},{"issue":"16","key":"10.1016\/j.prostaglandins.2017.08.006_bib0435","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1523\/JNEUROSCI.4531-05.2006","article-title":"Prostaglandin D2-mediated microglia\/astrocyte interaction enhances astrogliosis and demyelination in twitcher","volume":"26","author":"Mohri","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.08.006_bib0440","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2014.02.024","article-title":"Motor neuron death in ALS: programmed by astrocytes?","volume":"81","author":"Pirooznia","year":"2014","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.prostaglandins.2017.08.006_bib0445","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/nn.3857","article-title":"Prostaglandin D2 synthase\/GPR44: a signaling axis in PNS myelination","volume":"17","author":"Trimarco","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.08.006_bib0450","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1523\/JNEUROSCI.1407-13.2014","article-title":"Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-Induced sickness behavior model","volume":"34","author":"Haba","year":"2014","journal-title":"J. Neurosci."},{"issue":"314","key":"10.1016\/j.prostaglandins.2017.08.006_bib0455","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2016.07.050","article-title":"Prostaglandin D2 signaling mediated by the CRTH2 receptor is involved in MK-801-induced cognitive dysfunction","volume":"1","author":"Onaka","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0460","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.plefa.2012.03.009","article-title":"Eicosanoids in skin inflammation","volume":"88","author":"Nicolaou","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.08.006_bib0465","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bcp.2009.11.012","article-title":"Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytes","volume":"79","author":"Kanda","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0470","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.taap.2008.05.017","article-title":"UVB light upregulates prostaglandin synthases and prostaglandin receptors in mouse keratinocytes","volume":"232","author":"Black","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2017.08.006_bib0475","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.molimm.2011.08.023","article-title":"Distinct roles of prostaglandin D2 receptors in chronic skin inflammation","volume":"49","author":"Matsushima","year":"2011","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0480","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4049\/jimmunol.177.4.2621","article-title":"Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor","volume":"177","author":"Satoh","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0485","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaci.2010.07.006","article-title":"The prostaglandin D2 receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge","volume":"126","author":"He","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxn118","article-title":"Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms","volume":"21","author":"Boehme","year":"2009","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/dxn127","article-title":"A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation","volume":"21","author":"Boehme","year":"2009","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.08.006_bib0500","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1365-2222.2008.03007.x","article-title":"CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis","volume":"38","author":"Oiwa","year":"2008","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0505","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1468-3083.2009.03267.x","article-title":"Increased expression of CRTH2 on eosinophils in allergic skin diseases","volume":"24","author":"Yahara","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0510","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.0022-202X.2005.23932.x","article-title":"Differential expression of genes involved in skin homing, proliferation, and apoptosis in CD4+ T cells of patients with atopic dermatitis","volume":"125","author":"Hijnen","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0515","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4049\/jimmunol.1302080","article-title":"Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation","volume":"192","author":"Sarashina","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0520","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2340\/00015555-0759","article-title":"Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji\u2019s disease): a proposed mechanism of action","volume":"90","author":"Satoh","year":"2010","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0525","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imm.12112","article-title":"Indomethacin inhibits eosinophil migration to prostaglandin D2: therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis","volume":"140","author":"Kataoka","year":"2013","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.08.006_bib0530","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1096\/fj.12-218156","article-title":"The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias","volume":"27","author":"Khidhir","year":"2013","journal-title":"FASEB J."},{"issue":"126","key":"10.1016\/j.prostaglandins.2017.08.006_bib0535","first-page":"126ra34","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza Liu","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0540","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/jid.2012.398","article-title":"Prostaglandin D2 inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44","volume":"133","author":"Nelson","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.08.006_bib0545","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0625.2007.00639.x","article-title":"Prostanoid receptors in anagen human hair follicles","volume":"17","author":"Colombe","year":"2008","journal-title":"Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.08.006_bib0550","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00210-016-1257-z","article-title":"15-deoxy prostaglandin J2, the nonenzymatic metabolite of prostaglandin D2, induces apoptosis in keratinocytes of human hair follicles: a possible explanation for prostaglandin D2-mediated inhibition of hair growth","volume":"389","author":"Joo","year":"2016","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.08.006_bib0555","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"7203","key":"10.1016\/j.prostaglandins.2017.08.006_bib0560","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.08.006_bib0565","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"104","key":"10.1016\/j.prostaglandins.2017.08.006_bib0570","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2016.01.011","article-title":"Activation of the MAPK\/Akt\/Nrf2-Egr1\/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death","volume":"15","author":"Koyani","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.08.006_bib0575","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijcard.2014.03.086","article-title":"15-deoxy-\u039412,14-PGJ\u2082 promotes inflammation and apoptosis in cardiomyocytes via the DP2\/MAPK\/TNF\u03b1 axis","volume":"173","author":"Koyani","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.08.006_bib0580","first-page":"431","article-title":"Peripheral blood CD4+CRTH2+ cells in advanced stage non small cell lung cancer","volume":"5","author":"Karag\u00f6z","year":"2010","journal-title":"Cent. Eur. J. Med."},{"issue":"50","key":"10.1016\/j.prostaglandins.2017.08.006_bib0585","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.0805171105","article-title":"Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo","volume":"105","author":"Murata","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.08.006_bib0590","first-page":"2771","article-title":"The role of type d prostanoid receptors and PPAR\u03b3 in gastric cancer progression","volume":"34","author":"Fukuoka","year":"2014","journal-title":"Anticancer Res."},{"issue":"2014","key":"10.1016\/j.prostaglandins.2017.08.006_bib0595","article-title":"Polarization of ILC2 s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer","author":"Bie","year":"2014","journal-title":"J. Immunol. Res. [Internet]"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:00:59Z","timestamp":1761098459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317300151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":119,"alternative-id":["S1098882317300151"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.08.006","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of CRTH2\/DP2 beyond allergy and asthma","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}